✦ LIBER ✦

GSK3 inhibitors: development and therapeutic potential

✍ Scribed by Cohen, Philip; Goedert, Michel

Book ID: 109949519
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 269 KB
Volume: 3
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrd1415

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Profile: GSK-3 inhibitors: potential dru

Profile: GSK-3 inhibitors: potential drugs for neurodegenerative disorders

✍ David Gurwitz; Hagit Eldar-Finkelman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 86 KB

The Development of Potent and Selective

The Development of Potent and Selective Bisarylmaleimide GSK3 Inhibitors.

✍ Thomas A. Engler; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 29 KB

## Abstract For Abstract see ChemInform Abstract in Full Text.

The development and therapeutic potentia

The development and therapeutic potential of protein kinase inhibitors

✍ Philip Cohen 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 820 KB

Therapeutic Potential of Phosphoinositid

Therapeutic Potential of Phosphoinositide 3-Kinase Inhibitors

✍ Stephen Ward; Yannis Sotsios; James Dowden; Ian Bruce; Peter Finan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 107 KB

GSK-3 is a viable potential target for t

GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder

✍ Michael K. Rowe; Charlotte Wiest; De-Maw Chuang 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Bipolar disorder is a serious psychiatric condition that has been treated for over 50 years with lithium. Lithium is a well established glycogen synthase kinase-3 (GSK-3) inhibitor, suggesting that manipulating GSK-3 may have therapeutic value in treating bipolar disorder. GSK-3 is regulated by a wi

Glycogen Synthase Kinase-3 (GSK3): Infla

Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics

✍ Richard S. Jope; Christopher J. Yuskaitis; Eléonore Beurel 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 379 KB